FIDRISERTIB

FIDRISERTIB : Inhibitor of ACVR1

Structure

Information

  • ACVR1 (Mutant:WT, R206H)
  • Inhibitor
  • up to 100 nM

In Vitro Validations

Uniprot ID: Q04771
Target Class: Kinase
Target SubClass: TKL
Potency: IC50
Potency Value: 0.2 nM
Potency Assay: LanthaScreen binding assays using ALK2-R206H
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Activin receptor type-1, ACVRLK2, ACVR1, ACVR1_HUM ...

DOI Reference: 10.1126/scitranslmed.abp8334

Uniprot ID: Q04771
Target Class: Kinase
Target SubClass: TKL
Potency: IC50
Potency Value: 0.6 nM
Potency Assay: LanthaScreen binding assays using WT-ALK2
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Activin receptor type-1, ACVRLK2, ACVR1, ACVR1_HUM ...

DOI Reference: 10.1126/scitranslmed.abp8334

Uniprot ID: Q04771
Target Class: Kinase
Target SubClass: TKL
Potency: Kd
Potency Value: 1.2 nM
Potency Assay: Biochemical assay using recombinant ALK2-R206H
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Activin receptor type-1, ACVRLK2, ACVR1, ACVR1_HUM ...

DOI Reference: 10.1126/scitranslmed.abp8334

Uniprot ID: Q04771
Target Class: Kinase
Target SubClass: TKL
Potency: Kd
Potency Value: 2.1 nM
Potency Assay: Biochemical assay using recombinant ALK2-WT
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Activin receptor type-1, ACVRLK2, ACVR1, ACVR1_HUM ...

DOI Reference: 10.1126/scitranslmed.abp8334

In Cell Validations

In Vivo Data

Off-Target Selectivity Assesments

Potency assay (off target): Kinome profiling of BLU-782 showed high selectivity, with only four kinases exhibiting <100 nM protein binding affinity (WT, R206H, ALK-4, -6). In biochemical binding assays, BLU-782 potently bound ALK2-R206H, with at least 15-fold selectivity over other BMP type I and type II ALK family receptors.
Potency assay, off target (cells): Cellular IC50 values showed >100-fold selectivity of BLU-782 for ALK2-R206H over ALK1, ALK3, and ALK6.
I have extra information to add

SERP ratings and comments


No SERP comments found for FIDRISERTIB